Lori Macomber
Direttore Finanziario/CFO presso LEGEND BIOTECH CORPORATION
Patrimonio netto: 337 859 $ in data 30/04/2024
Profilo
Lori Macomber is currently the Chief Financial Officer at Legend Biotech Corp.
She previously worked as the Business Unit Controller at AMETEK, Inc. from 2018 to 2019, the Assistant VP-Finance Site Leader at Eli Lilly & Co. from 2010 to 2017, and the Controller & Chief Financial Officer-US Region at Cello Health Ltd.
from 2017 to 2018.
Ms. Macomber obtained her undergraduate degree from The Pennsylvania State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LEGEND BIOTECH CORP.
0.01% | 31/12/2022 | 15 212 ( 0.01% ) | 337 859 $ | 30/04/2024 |
Posizioni attive di Lori Macomber
| Società | Posizione | Inizio |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Direttore Finanziario/CFO | 09/05/2022 |
Precedenti posizioni note di Lori Macomber
| Società | Posizione | Fine |
|---|---|---|
| AMETEK, INC. | Corporate Officer/Principal | 01/09/2019 |
| CELLO HEALTH PLC | Comptroller/Controller/Auditor | 01/02/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/04/2017 |
Formazione di Lori Macomber
| The Pennsylvania State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| AMETEK, INC. | Producer Manufacturing |
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
Cello Health Ltd.
 Cello Health Ltd. Miscellaneous Commercial ServicesCommercial Services Cello Health Plc provides strategic marketing services. It operates through two segments: Cello Health and Cello signal. The Cello Health segment provides market research, consulting, and communications services principally to its pharmaceutical and healthcare clients and Signal segment provides market research and direct communications services principally to its consumer facing clients. The company was founded by Mark Coleridge Scott and Kevin Barrie Steeds on May 5, 2004 and is headquartered in London, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Lori Macomber